title: Sirtuins in hematological aging and malignancy.
abstract: Aging of the hematological system causes anemia, reduced immunity, and increased incidence of hematological malignancies. Hematopoietic stem cells (HSCs) play a crucial role in this process as their functions decline during aging. Sirtuins are a family of protein lysine modifying enzymes that have diverse roles in regulating metabolism, genome stability, cell proliferation, and survival, and have been implicated in mammalian aging and longevity. Here we provide an updated overview of sirtuins in aging research; particularly, how increased activity of SIRT1, SIRT3, or SIRT6 improves several aging parameters, and may possibly increase lifespan in mice. We review the literature on how sirtuins may play a role in HSC aging and hematological malignancies, and how key signaling pathways of HSCs may be affected by sirtuins. Among them, SIRT1 plays a critical role in chronic myelogenous leukemia, an age-dependent malignancy, and inhibition of SIRT1 sensitizes leukemic stem cells to tyrosine kinase inhibitor treatment and blocks acquisition of resistant oncogene mutations. In-depth understanding of sirtuins in HSC aging and malignancy may help design novel strategies to deter hematological aging and improve treatment of hematological malignancies.
authors.affiliation: Department of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California 91010, USA.
authors.forename: Mendel
authors.initials: M
authors.lastname: Roth
authors.affiliation: Department of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California 91010, USA.
authors.forename: Zhiqiang
authors.initials: Z
authors.lastname: Wang
authors.affiliation: Department of Cancer Biology, Beckman Research Institute, City of Hope, Duarte, California 91010, USA.
authors.forename: Wen Yong
authors.initials: WY
authors.lastname: Chen
mesh_terms: D000818:Animals; D016922:Cellular Senescence; D019337:Hematologic Neoplasms / Q000209:etiology*; D006412:Hematopoietic Stem Cells / Q000502:physiology*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000209:etiology; D009369:Neoplasms / Q000209:etiology*; D015398:Signal Transduction; D037761:Sirtuins / Q000502:physiology*
chemical_list: D037761:Sirtuins